ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 833 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR How Do Black People with Cancer View Clinical Research? November 15, 2024 10 Ways to Keep Your Family Safe from the Coronavirus Outbreak January 29, 2020 Emergency presentations: what are they, and what do they mean for... April 7, 2022 Noninferiority of OS with 3 Months Compared to 6 Months of... January 20, 2026 Load more HOT NEWS Copanlisib Shows Promising Clinical Activity in Select Tumours with PIK3CA Mutation... Neoadjuvant Treatment with Dual Immune Checkpoint Inhibitors Plus Chemotherapy Produces Numerically... One Million Masks Donated! But GreaterGood Will Continue to Help Where... How Some Brain Tumors Hijack the Mind to Grow
